Viewing Study NCT03025269


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-01-02 @ 12:43 PM
Study NCT ID: NCT03025269
Status: COMPLETED
Last Update Posted: 2022-03-11
First Post: 2017-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
Sponsor: University at Buffalo
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-11-15
Start Date Type: ACTUAL
Primary Completion Date: 2022-01-08
Primary Completion Date Type: ACTUAL
Completion Date: 2022-01-08
Completion Date Type: ACTUAL
First Submit Date: 2017-01-16
First Submit QC Date: None
Study First Post Date: 2017-01-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-03-09
Last Update Post Date: 2022-03-11
Last Update Post Date Type: ACTUAL